SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-16-144634
Filing Date
2016-09-14
Accepted
2016-09-14 16:16:32
Documents
10
Effectiveness Date
2016-09-14

Document Format Files

Seq Description Document Type Size
1 S-8 a16-17560_1s8.htm S-8 175938
2 EX-4.04 a16-17560_1ex4d04.htm EX-4.04 182843
3 EX-4.05 a16-17560_1ex4d05.htm EX-4.05 67656
4 EX-4.06 a16-17560_1ex4d06.htm EX-4.06 50950
5 EX-4.07 a16-17560_1ex4d07.htm EX-4.07 41439
6 EX-4.08 a16-17560_1ex4d08.htm EX-4.08 83175
7 EX-4.09 a16-17560_1ex4d09.htm EX-4.09 46032
8 EX-5.01 a16-17560_1ex5d01.htm EX-5.01 24717
9 EX-23.2 a16-17560_1ex23d2.htm EX-23.2 3790
10 GRAPHIC g175601koi001.jpg GRAPHIC 8709
  Complete submission text file 0001104659-16-144634.txt   689737
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: S-8 | Act: 33 | File No.: 333-213627 | Film No.: 161885257
SIC: 2834 Pharmaceutical Preparations